Therefore, the accumulation and likely the tumor infiltration of FoxP3+ T-cells mark the presence of tumor-rejecting antigen-specific CD8+ T cells, which in turn serves as a marker for an effective T-cell response [55]. The gene discussed is CD8A; the disease is neoplasm.